Atlas Trials

A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy

Clinical trial NCT05115110 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05115110
Sponsor
Hoffmann-La Roche
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Spinal Muscular Atrophy (SMA)
Start date
2022-06-02
Primary completion
2026-10-28
Enrollment
259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.